Anthrax
📧 Sign up to get email alerts when something new happens for Anthrax.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-19Clinical Trial Update: Ciprofloxacin BioThrax Co-Administration Study [Phase 2]
A Phase 2 study evaluating the co-administration of ciprofloxacin with BioThrax (anthrax vaccine adsorbed) in anthrax conditions; results we…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults [Phase 1]
Phase 1 study assessing safety, tolerability, and immunogenicity of AV7909 anthrax vaccine in healthy adults completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule [Phase 4]
A Phase 4 study evaluating the immunogenicity and safety of a dose-sparing schedule for BioThrax (anthrax vaccine adsorbed) completed with r…
-
CLINICAL_TRIALS trial_result · 2013-12-09Clinical Trial Update: Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects [Phase 1]
This Phase 1 dose-escalation study of Valortim (MDX-1303) administered intravenously in healthy subjects has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults [Phase 3]
Phase 3 trial update on a three-dose BioThrax regimen for post-exposure prophylaxis in healthy adults, focusing on immunogenicity and safety…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Efficacy and Safety of Anthrax Vaccine, GC1109 [Phase 1]
This update reports the completion of a Phase 1 clinical trial evaluating the safety and potential efficacy of the GC1109 Anthrax Vaccine co…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults [Phase 1]
A Phase 1 study evaluated a new intramuscular anthrax vaccine in healthy adults and has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Anthrax-rPA: Safety, Tolerability, Immunogenicity [Phase 1]
Phase 1 trial of Anthrax-rPA evaluated safety, tolerability, and immunogenicity and has completed, reporting early safety and immune respons…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: UMD rPA Regimen Trial in Adults [Phase 2]
A Phase 2 trial evaluating the UMD rPA regimen in adults with anthrax has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: Ph1 Study of Valortim and Doxycycline in Humans [Phase 1]
A Phase 1 study evaluating Valortim in combination with doxycycline for anthrax was terminated. The trial status was TERMINATED.
-
CLINICAL_TRIALS other · 2010-08-10Clinical Trial Update: Ph1 Study of Valortim and Ciprofloxacin in Humans [Phase 1]
A Phase 1 study of Valortim in combination with Ciprofloxacin for anthrax has been suspended.
-
CLINICAL_TRIALS trial_result · 2008-09-15Clinical Trial Update: Phase II Study of Range and Schedule of rPA Doses [Phase 2]
Phase II study evaluating range and scheduling of recombinant protective antigen (rPA) doses for prevention of anthrax; study completed.
-
CLINICAL_TRIALS trial_result · 2008-09-15Clinical Trial Update: Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed [Phase 2]
Phase 2 clinical trial comparing safety, tolerability, and immunogenicity of a recombinant anthrax vaccine with Anthrax Vaccine Adsorbed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Plasmapheresis of Anthrax-Vaccinated Subjects for Production of Anthrax Immune Globulin
A completed NIH clinical trial evaluated plasmapheresis of anthrax-vaccinated subjects to produce anthrax immune globulin.